CaMKII plays a part in the chondrogenesis of bone marrow-derived mesenchymal stem cells.

AIMS The purpose of the study is to observe the functions of calcium/calmodulin dependent protein kinase II (CaMKII) in the induced chondrogenic differentiation of bone marrow derived mesenchymal stem cells (BMSCs). METHODS BMSCs was in vitro isolated and cultured for induced chondrogenesis. Western blot was used to ascertain the expression of CaMKII and phosphorylated CaMKII (PCaMKII, activatory CaMKII) in chondrogenic induced BMSCs. MTT method was utilized to observe the impact of CaMKII on the proliferation of BMSCs. The generation of cartilage matrix in BMSCs cells was detected by toluidine blue staining. The levels of cartilage marker genes COL2A1, Aggrecan and SOX9 in BMSCs were gained by real-time fluorescence quantitative polymerase chain reaction (RT-QPCR). Finally, BMSCs proliferation, cartilage matrix generation and the changes of COL2A1, Aggrecan and SOX9 were surveyed after CaMKII being blocked by CaMKII inhibitor KN93. RESULTS Expression of CaMKII and PCaMKII could be found in chondrogenic induced BMSCs. CaMKII had no significant influence on BMSCs proliferation, but the toluidine blue staining was obviously lighter, indicating a significant decline in the expression of COL2A1, Aggrecan and SOX9. CONCLUSION As one of the factors influencing the chondrogenic capacity of BMSCs, CaMKII does not impact on BMSCs proliferation, but it can inhibit the chondrogenic ability of BMSCs by influencing its differentiation.

[1]  Yingxiao Fu,et al.  Involvement of the Ca2+ signaling pathway in osteoprotegerin inhibition of osteoclast differentiation and maturation , 2015, Journal of veterinary science.

[2]  M. Illario,et al.  A novel crosstalk between calcium/calmodulin kinases II and IV regulates cell proliferation in myeloid leukemia cells. , 2015, Cellular signalling.

[3]  A. de Haan,et al.  CaMKII content affects contractile, but not mitochondrial, characteristics in regenerating skeletal muscle , 2014, BMC Physiology.

[4]  Ming Liu,et al.  The inhibitor of calcium/calmodulin-dependent protein kinase II KN93 attenuates bone cancer pain via inhibition of KIF17/NR2B trafficking in mice , 2014, Pharmacology Biochemistry and Behavior.

[5]  Mohamadreza Baghaban Eslaminejad,et al.  Mesenchymal stem cells as a potent cell source for articular cartilage regeneration , 2014 .

[6]  Y. Huang,et al.  Wnt signaling pathway in rheumatoid arthritis, with special emphasis on the different roles in synovial inflammation and bone remodeling. , 2013, Cellular signalling.

[7]  H. Kwon,et al.  Myocilin Stimulates Osteogenic Differentiation of Mesenchymal Stem Cells through Mitogen-activated Protein Kinase Signaling* , 2013, The Journal of Biological Chemistry.

[8]  L. Racioppi.  CaMKK2: a novel target for shaping the androgen-regulated tumor ecosystem. , 2013, Trends in molecular medicine.

[9]  G. Domínguez.  Deciphering the epigenetic network in colorectal cancer , 2013, The Journal of pathology.

[10]  Z. Meng,et al.  CaMKII γ, a critical regulator of CML stem/progenitor cells, is a target of the natural product berbamine. , 2012, Blood.

[11]  A. Adesida,et al.  Current clinical therapies for cartilage repair, their limitation and the role of stem cells. , 2012, Current stem cell research & therapy.

[12]  H. Madry,et al.  Clinical potential and challenges of using genetically modified cells for articular cartilage repair , 2011, Croatian medical journal.

[13]  C. Jorgensen,et al.  Mesenchymal stem cell-based therapies in regenerative medicine: applications in rheumatology , 2011, Stem Cell Research & Therapy.

[14]  M. Shakibaei,et al.  Mesenchymal stem cells as a potential pool for cartilage tissue engineering. , 2008, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[15]  J. Ghysdael,et al.  The calcineurin/NFAT signaling pathway: A NOVEL therapeutic target in leukemia and solid tumors , 2008, Cell cycle.

[16]  Xiaoyun Xing,et al.  Computational identification and functional validation of regulatory motifs in cartilage-expressed genes. , 2007, Genome research.

[17]  P. An,et al.  KN-93, a specific inhibitor of CaMKII inhibits human hepatic stellate cell proliferation in vitro. , 2007, World journal of gastroenterology.

[18]  M. Eren,et al.  Calmodulin kinase II inhibition protects against myocardial cell apoptosis in vivo. , 2006, American journal of physiology. Heart and circulatory physiology.

[19]  E. Olson,et al.  CaM kinase II selectively signals to histone deacetylase 4 during cardiomyocyte hypertrophy. , 2006, The Journal of clinical investigation.

[20]  N. Cheshire,et al.  Canonical pathway of nuclear factor kappa B activation selectively regulates proinflammatory and prothrombotic responses in human atherosclerosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[21]  B. Kobilka,et al.  Linkage of beta1-adrenergic stimulation to apoptotic heart cell death through protein kinase A-independent activation of Ca2+/calmodulin kinase II. , 2003, The Journal of clinical investigation.

[22]  Katsuhiko Mikoshiba,et al.  The Wnt/calcium pathway activates NF-AT and promotes ventral cell fate in Xenopus embryos , 2002, Nature.

[23]  M. Saito,et al.  Human autologous culture expanded bone marrow mesenchymal cell transplantation for repair of cartilage defects in osteoarthritic knees. , 2002, Osteoarthritis and cartilage.

[24]  L. Bonassar,et al.  Tissue-engineered human auricular cartilage demonstrates euploidy by flow cytometry. , 2002, Tissue engineering.

[25]  B. Bresnihan,et al.  Early joint erosions and serum levels of matrix metalloproteinase 1, matrix metalloproteinase 3, and tissue inhibitor of metalloproteinases 1 in rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[26]  K. Malik,et al.  Ca2+/calmodulin-dependent protein kinase II and cytosolic phospholipase A2 contribute to mitogenic signaling in myeloblastic leukemia U-937 cells. , 2001, The Journal of pharmacology and experimental therapeutics.

[27]  R. Eavey,et al.  Engineering Autogenous Cartilage in the Shape of a Helix Using an Injectable Hydrogel Scaffold , 2000, The Laryngoscope.

[28]  C. Glass,et al.  Differential use of CREB binding protein-coactivator complexes. , 1998, Science.

[29]  S. Reed,et al.  Growth and Development Symposium: Stem cell therapy in equine tendon injury. , 2013, Journal of animal science.

[30]  R. Ginnan,et al.  Calcium/calmodulin-dependent protein kinase II-delta isoform regulation of vascular smooth muscle cell proliferation. , 2007, American journal of physiology. Cell physiology.

[31]  Mark E. Anderson,et al.  L-type Ca2+ channel facilitation mediated by phosphorylation of the beta subunit by CaMKII. , 2006, Molecular cell.

[32]  P. Hogan,et al.  Transcription factors of the NFAT family: regulation and function. , 1997, Annual review of immunology.

[33]  T. Yamauchi,et al.  [Ca2(+)-calmodulin-dependent protein kinase II]. , 1990, Seikagaku. The Journal of Japanese Biochemical Society.